KYOWA HAKKO BIO CO.,LTD. Sustainability Profile
Kyowa Hakko Bio Co., Ltd., a prominent player in the biotechnology industry, is headquartered in Japan. Established in 1949, the company has made significant strides in the development of amino acids, nucleic acids, and fermentation products, catering to diverse sectors such as pharmaceuticals,
DitchCarbon Score
How does KYOWA HAKKO BIO CO.,LTD.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
KYOWA HAKKO BIO CO.,LTD.'s score of 86 is higher than 91% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
KYOWA HAKKO BIO CO.,LTD.'s reported carbon emissions
In 2023, Kyowa Hakko Bio Co., Ltd. reported total carbon emissions of approximately 305,000 kg CO2e. This figure includes Scope 1 emissions of about 33,000,000 kg CO2e, Scope 2 emissions of around 96,000,000 kg CO2e, and Scope 3 emissions totalling approximately 176,000,000 kg CO2e. The combined Scope 1 and 2 emissions amounted to about 129,000,000 kg CO2e. Comparatively, in 2022, the company recorded total emissions of approximately 363,000 kg CO2e, with Scope 1 at about 40,000,000 kg CO2e, Scope 2 at around 131,000,000 kg CO2e, and Scope 3 at approximately 193,000,000 kg CO2e. This indicates a reduction in total emissions from 2022 to 2023. Kyowa Hakko Bio has set ambitious reduction targets, aiming for a 50% reduction in Scope 1 and 2 emissions and a 30% reduction in Scope 3 emissions by 2030, based on 2019 levels. These targets reflect the company's commitment to addressing climate change and reducing its carbon footprint. The emissions data is cascaded from its parent company, Kirin Holdings Company, Limited, which oversees various sustainability initiatives, including those related to the Science Based Targets initiative (SBTi) and other climate-related commitments.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2001 | 2002 | 2005 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|---|---|
| Scope 1 | 708,202,000 | 000,000,000 | 000,000,000 | 00,000 | 00,000 | 00,000 | 00,000,000 | 00,000,000 |
| Scope 2 | 1,176,000 | 0,000,000 | - | 000,000 | 000,000 | 000,000 | 000,000,000 | 00,000,000 |
| Scope 3 | 650,000 | 000,000 | - | 000,000 | 000,000 | 000,000 | 000,000,000 | 000,000,000 |
How Carbon Intensive is KYOWA HAKKO BIO CO.,LTD.'s Industry?
How Carbon Intensive is KYOWA HAKKO BIO CO.,LTD.'s Location?
KYOWA HAKKO BIO CO.,LTD.'s Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
KYOWA HAKKO BIO CO.,LTD. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
